CSF2 and neoplasm: To determine the efficacy of immunotherapy in aggressive malignant melanoma we electrically delivered a plasmid encoding GM-CSF, in combination with T-reg depleting anti-CD25 to mice receiving the melanoma tumor cell line B16F10.